文献速递乳房整形与再造显微修复重建

感染性乳房装置取出后自体与假体重建的 surgery 与患者报告结局比较

Surgical and Patient-Reported Outcomes of Autologous versus Implant-Based Reconstruction following Infected Breast Device Explantation.
PubMed 文献 · Plast Reconstr Surg · 2022-03-29

该回顾性研究纳入2006至2019年因假体感染取出后行第二次重建的130例乳房(假体重建86例,游离皮瓣44例),比较手术与患者报告结局。两组总体及主要并发症发生率无显著差异,但假体组再次感染与重建失败率更高,放疗患者中失败率更高,皮瓣组乳房满意度评分更高。

要点

  • 假体组再次感染27%显著高于皮瓣组2%,重建失败21%显著高于5%
  • 既往放疗患者中假体组重建失败44%显著高于皮瓣组7%
  • 皮瓣组乳房满意度评分73.7±20.1显著高于假体组48.5±27.9

核心结论

  • 因感染取出假体后,假体与游离皮瓣重建的总体及主要并发症发生率相似,但假体重建再次感染率与重建失败率更高,乳房满意度评分更低。
  • 作者认为,对既往放疗且因感染导致假体失败的患者,整形外科医生应强烈考虑自体组织重建。

研究设计与样本

  • 回顾性研究,纳入2006至2019年因感染取出假体后行第二次重建(假体或游离皮瓣)的患者。
  • 研究期间共完成6093例假体乳房重建,其中130例乳房符合纳入标准:假体重建86例(66%),游离皮瓣44例(34%)。

主要发现

  • 总体并发症:皮瓣组36% vs 假体组25%(p=0.2),无显著差异。
  • 主要并发症:皮瓣组21% vs 假体组20%(p=0.95),无显著差异。
  • 再次感染:假体组27% vs 皮瓣组2%(p=0.0007),假体组更高。
  • 重建失败:假体组21% vs 皮瓣组5%(p=0.019),假体组更高。
  • 放疗患者重建失败:假体组44% vs 皮瓣组7%(p=0.02)。

关键数值与推荐

  • 证据等级:治疗性,III级。

临床怎么用

  • 作者建议,对既往放疗且因感染导致假体重建失败的患者,整形外科医生应强烈考虑自体组织重建。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Implant-based breast reconstruction infections often require implant explantation. Whereas some plastic surgeons pursue autologous reconstruction following the first implant-based breast reconstruction failure caused by infection, others argue that a second attempt is acceptable. METHODS: The authors conducted a retrospective study of patients who underwent a second reconstruction attempt with implant-based or free flap breast reconstruction following explantation because of infection between 2006 and 2019. Surgical and patient-reported outcomes were compared between the two groups. RESULTS: A total of 6093 implant-based breast reconstructions were performed during the study period, of which 130 breasts met our inclusion criteria [implant-based, n = 86 (66 percent); free flap, n = 44 (34 percent)]. No significant differences in rates of overall (25 percent versus 36 percent; p = 0.2) or major (20 percent versus 21 percent; p = 0.95) complications were identified between the free flap and implant-based cohorts, respectively. Implant-based breast reconstruction patients were more likely to experience a second infection (27 percent versus 2 percent; p = 0.0007) and reconstruction failure (21 percent versus 5 percent; p = 0.019). Among irradiated patients, reconstruction failure was reported in 44 percent of the implant-based and 7 percent of the free flap cohorts (p = 0.02). Free flap patients reported significantly higher scores for Satisfaction with Breasts (73.7 ± 20.1 versus 48.5 ± 27.9; p = 0.0046). CONCLUSIONS: Following implant-based breast reconstruction explantation because of infection, implant-based and free flap breast reconstruction had similar rates of overall and major complications; however, implant-based breast reconstruction had considerably higher rates of infection and reconstructive failures and lower patient-reported scores for Satisfaction with Breasts. Given the high rates of implant-based breast reconstruction failure in patients with prior radiotherapy and infection-based failure, plastic surgeons should strongly consider autologous reconstruction in this patient population. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, III.

来源:Plast Reconstr Surg,查看原文。版权归原作者所有。

引用

  1. Asaad M, Slovacek C, Mitchell D, et al. Surgical and Patient-Reported Outcomes of Autologous versus Implant-Based Reconstruction following Infected Breast Device Explantation. Plast Reconstr Surg. 2022. PMID: 35349553. doi:10.1097/PRS.0000000000009091

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。